Neon improves predictions for CD4-stimulating tumor antigens

In the latest step toward breaking the barrier to identifying neoantigens displayed on MHCII, Neon has generated a systems biology model that outperforms publicly available predictors.

The development brings immuno-oncology closer to personalized therapies directing CD4+ T cells against tumor neoantigens.

A growing number

Read the full 421 word article

User Sign In